期刊文献+

2型糖尿病患者血糖波动对微血管病变的影响 被引量:3

The influence on microangiopathy in type 2 diabetes due to the fluctuation of blood glucose
原文传递
导出
摘要 目的探讨2型糖尿病患者血糖波动与微血管病变之间的关系。方法分析了822例2型糖尿病住院患者血压、血脂、全天7点血糖、体重指数、糖化血红蛋白、空腹胰岛素、尿白蛋白排泄率、餐前血糖曲线下面积和餐后血糖曲线下面积,采用稳态模式评价胰岛素抵抗。根据微血管病变数量分为无微血管病变组、1种微血管病变组、2种微血管病变组和3种微血管病变组。依据微血管病变数量、不同时间血糖曲线下面积进行分析。结果随着微血管病变数目增多,空腹血糖、尿白蛋白排泄率、收缩压、舒张压、体重指数和餐前血糖曲线下面积呈升高趋势(P〈0.05)。累加Logistic回归分析显示:舒张压和早餐后血糖曲线下面积是影响所有2型糖尿病患者微血管病变独立的危险因素。结论2型糖尿病患者微血管病变的发生发展可能与早餐后血糖波动密切相关。 Objective To investigate the relationship between microangiopathy and the fluctuation of blood glucose in type 2 diabetes. Methods Eight hundred and twenty-two in-patient type 2 diabetes mellitus(T2DM) were analyzed for the blood pressure, serum lipids, blood glucose throughout the day, body mass index(BMI), glycosylated hemoglobin( HbA1 c), fasting insulin(FINS), urinary albumin excretion rates( UAER), blood glucose under curve area before and after meal( AUC1, AUC2). Homeostasis model assessment(HOMA)was applied to assess the status of insulin resistance. Results Were analyz, ed according to the number of microangiopathy and different time blood glucose under curve area. Results The levels of fasting blood glucose ( FBG ), UAER, systolic blood pressure ( SBP ), diastolic blood pressure (DBP) ,BMI,AUC1 were significantly were elevated step by step accompany by the number of microangiapathy increased(P 〈 0.05 ). Cumulative Logistic regression analysis showed that the risk factors of D]3P and AUC3 affected clustering of microangiopathy in T2DM. Conclusion The fluctuations in blood glucose after breakfast is closely related to occurrence and development of microangiopathy in T2DM.
出处 《临床内科杂志》 CAS 2010年第4期267-269,共3页 Journal of Clinical Internal Medicine
关键词 糖尿病 2型 血糖 微血管疾病 Diabetes mellitus,type 2 Blood glucose Microangiopathy
  • 相关文献

参考文献11

  • 1Fiuza M,Cortez-Dias N,Martins S,et al.Metabolic syndrome in Portugal:prevalence and implications for cardiovascular risk-results from the VALSIM Study.Rev Port Cardiol,2008,27:1495-1529.
  • 2Baqi Z,Feher A,Beleznai T,et al.Preserved coronary arteriolar dilatation in patients with type 2 diabetes mellitus:Implications for reactive oxygen species.Pharmacol Rep,2009,61:99-104.
  • 3Sajjadi F,Mohammadifard N,Kelishadi R,et al.Clustering of coronary artery disease risk factors in patients with ty pe 2 diabetes and impaired glucose tolerance.East Mediterr Health J,2008,14:1080-1089.
  • 4Bibra H,Siegmund T,Ceriello A,et al.Optimized postprandial glucose control is associated with improved cardiac/vascular function-comparison of three insulin regimens in well-controlled type 2 diabetes.Horm Metab Res,2009,41:109-115.
  • 5The DECODE Study Group.Glucose tolerance and mortality:comparison of WHO and American Diabetes Association diagnostic criteria.Lancet,1999,354:617-621.
  • 6刘军,刘芳,陈影,徐东丽,姚庆姑.2型糖尿病患者心血管危险因素集簇现象[J].复旦学报(医学版),2004,31(2):171-175. 被引量:18
  • 7刘军,查英,盛励,陈灶萍.2型糖尿病患者代谢紊乱与血管并发症的关系[J].临床内科杂志,2005,22(11):764-766. 被引量:2
  • 8刘军,查英,盛励,陈灶萍.糖尿病患者住院费用研究[J].临床荟萃,2005,20(21):1219-1222. 被引量:6
  • 9Stratton IM,Adler AL,Neil HA,et al.Association of glycaemia with macrovaseular and microvascular complications of type 2 diabetes(UKPDS 35):prospective observational study.BMJ 2000,321:405-412.
  • 10Monner L,Lapinski H,Colette C.Contribution of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetes variations with increasing levels of HbAlc.Diabetes care,2003,26:881-885.

二级参考文献48

  • 1金惠铭.加强微血管病发病机制的研究[J].中国微循环,2006,10(2):77-78. 被引量:10
  • 2O'BRIEN J A, SHOMPHE L A, KAVANAGH P L, a al.Direct medical costs of complications resulting from type 2 diabetes in the U. S[J]. Diabetes Care, 1998,21(7) : 1122-1128.
  • 3HOGAN P,DALL T,NIKOLOV P. Economic costs of diabetes in the U. S in 2002[J]. Diabetes Care, 2003,26(3):917-932.
  • 4GRAY A, RAIKOU M, McGUIRE A,et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41) [J]. BMJ, 2000,320(7246):1373-1378.
  • 5CERIELLO A, SECHI L A. Management of cardiovascular risk in diabetic patients: evolution or revolution? [J]. Diabetes Nutr Metab, 2002,15 (2) : 121-127.
  • 6Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in united states adults. Circulation ,2004,110:1245-1250.
  • 7World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Part 1 :Diagnosis and Classification of Diabetes Mellitus. Geneva,World Health Org, 1999 (WHO/NCD/NCS99.2).
  • 8Klein BEK, Klein R, Lee KE, et al. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in beaver dam.Diabetes Care,2002,25:1790-1794.
  • 9Mcneill AM, Rosamond WD, Girman C J, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care ,2005,28:385-390.
  • 10Resnick HE, Jones K, Ruotolo G, et al. Insulin resistance, the metabolic syndrome,and risk of incident cardiovascular disease in nondiabetic american indians. Diabetes Care,2003,26:861-867.

共引文献34

同被引文献27

  • 1任伟,叶山东.胰岛素样生长因子-1与糖尿病肾病关系的研究进展[J].国外医学(老年医学分册),2006,27(5):229-232. 被引量:10
  • 2Ma L, Murea M, Snipes JA, et al. An ACACB variant implicatedin diabetic nephropathy associates with bo dy mass index and geneexpression inobese subjects [ J ] . PLoS One, 2013 , 8 ( 2 ):e56193. doi: 10. 1371/journal, pone. 0056193.
  • 3Levin-laina N, Iaina A, Raz I. The emerging role of NO and IGF-1 in early renal hypertrophy in STZ-induced diabetic rats [ J ],Diabetes Metab Res Rev, 2011,27(3) :235-243. doi: 10. 1002/drnrr. 1172.
  • 4Jefferson JA, Shankland SJ,Pichler RH. Proteinuria in diabetickidney disease : a mechanistic viewpoint [J]. Kidney Int, 2008 ,74(1) :22-36. doi: 10. 1038/ki. 2008. 128.
  • 5Nakhoul F, Nakhoul N,Asleh R, et al. Is the Hp 2-2 diabeticmouse model a good model to study diabetic nephropathy? [J].Diabetes Res Clin Pract, 2013,100(3) :289-297. doi: 10. 1016/j. diabres. 2013. 02. 004.
  • 6Mizuno S, Nakamura T. Suppressions of chronic glomerularinjuries and TGF-betal production by HGF in attenuation ofmurine diabetic nephropathy [ J ] . Am J Physiol Renal Physiol,2004,286(1) :F134-143.
  • 7Chen X, Chen Z, Wang H, et al. Plasmid pUDK-HGF encodinghuman hepatocyte growth factor gene attenuates gentamicin-induced kidney injury in rats [ J ]. Exp Toxicol Pathol, 2012,65(5): 541-547. doi: 10. 1016/j. etp. 2012. 03. 003.
  • 8Afsar B, Elsurer R, Giiner E, et al. Which anthropometricparameter is best related with urinary album in excretion andcreatinine clearance in type 2 diabetes : body mass index, waistcircumference,waist-to-hip ratio,or conicity index? [ J]. J RenNutr, 2011,21(6) :472478. doi: 10. 1053/j. jm. 2010. 12. 003.
  • 9谢飞舟,施冬云,肖玲,刘精东,刘珊林.2型糖尿病葡萄糖应激与抗氧化代偿的变化[J].复旦学报(医学版),2009,36(1):23-27. 被引量:25
  • 10陈莉丽,李强,王薇,崔璨,于萍,鲍莉莉,王君,周健,包玉倩,贾伟平,孙玉倩,张巾超.应用持续血糖监测系统评估2型糖尿病患者一级亲属的糖代谢特征[J].中华医学杂志,2009,89(10):655-658. 被引量:10

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部